Skip to content
  • Home
  • About Us
    • Our Research Center
    • Our Laboratory
    • FAQ
  • Research
    • AI-MDIP
    • Drug Discovery
  • $PCH Token
    • Tokenomics
    • Advanced Staking Model
    • Buyback and Burn
  • Blog
  • Contact
APPLY FOR WHITELIST
GET IN TOUCH

Buyback & Burn Mechanism

10% of platform revenue fuels permanent token burns

Reducing $PCH Supply Through Revenue-Powered BuybacksLong-Term Value Preservation

https://pharmatech-ai.com/wp-content/uploads/2025/05/Buyback-and-Burn.png

Real money flows into PCHBuyback & Burn

10% of all Revenues
We use 10 percent of our yearly revenues for buybacks on CEX and DEX. Purchased tokens are permanently burned by sending them to a null address, reducing the circulating supply.
Deflationary Pressure & Scarcity
By systematically removing PCH tokens from circulation, the buyback & burn mechanism increases scarcity over time, creating upward pressure on the token’s value as demand grows.
Positive Feedback Loop
Increased platform adoption leads to higher revenue, fueling larger buybacks and burns. This reinforces staking rewards and incentivizes long-term holding.
Increases Holder Equity
Every burned $PCH token effectively raises the ownership % of remaining holders, aligning incentives with long-term growth over pump-and-dump behavior.
https://pharmatech-ai.com/wp-content/uploads/2025/05/PCH-Buyback-and-Burn.png
https://pharmatech-ai.com/wp-content/uploads/2025/04/Main-reverse-transparent.png

Revolutionizing drug research with AI-MDIP, accelerating the development of new drug combinations and medications to be faster and more cost-effective.

Company

Pharmatech AI Ltd.
86-90 Paul Street, 3rd Floor
EC2A 4NE, London
United Kingdom

info@pharmatech-ai.com
Research Center

Libnower Landstr. 1
17390 Murchin
Mecklenburg-Vorpommern
Germany

info@pharmatech-ai.com
Company
  • Pharmatech AI (PCH)
  • AI-MDIP
  • Our Laboratory
  • FAQ
  • Our Research Center
Get In Touch

© 2025 Pharmatech AI Ltd.. All rights reserved

  • Imprint
  • Privacy Policy